You are here

  • Home
  • Archive
  • Volume 76, Issue 9
  • Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis

 

Online download statistics by month:

Online download statistics by month: May 2017 to March 2024

AbstractFullPdf
May 201751143579
Jun 201772315259
Jul 2017370370354
Aug 2017833840444
Sep 2017530534322
Oct 2017336337297
Nov 2017321322276
Dec 2017424426288
Jan 2018453454267
Feb 2018350328211
Mar 201846445568
Apr 201830730784
May 201836536782
Jun 2018246248106
Jul 201821721760
Aug 201827627666
Sep 201822422464
Oct 201823023164
Nov 201823423445
Dec 201818818831
Jan 201921221034
Feb 201916816543
Mar 201914913547
Apr 201911010640
May 201911411327
Jun 201912512337
Jul 2019797636
Aug 2019989244
Sep 2019766925
Oct 2019969044
Nov 2019817226
Dec 2019938648
Jan 2020838128
Feb 2020908831
Mar 2020858633
Apr 2020787849
May 2020717129
Jun 2020908944
Jul 2020787741
Aug 2020929228
Sep 2020939340
Oct 202013713642
Nov 202012712640
Dec 2020929140
Jan 2021828237
Feb 202110310132
Mar 2021989831
Apr 2021818129
May 2021959426
Jun 2021949332
Jul 2021746930
Aug 2021777621
Sep 202111911324
Oct 202112111844
Nov 2021959243
Dec 202110210239
Jan 202211711936
Feb 202213413436
Mar 202217517742
Apr 202215916238
May 202217919052
Jun 202211511517
Jul 2022929015
Aug 202212111928
Sep 202217217138
Oct 202211311519
Nov 202210410332
Dec 2022736919
Jan 20231039927
Feb 202310410018
Mar 202312311621
Apr 2023908631
May 202310910426
Jun 2023878524
Jul 202311110324
Aug 2023898932
Sep 202310510422
Oct 202322021031
Nov 202326124243
Dec 202317415428
Jan 202410710424
Feb 202410710425
Mar 202412511485
Total13572147586084